Meeting
2020 ASCO Virtual Scientific Program
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death.
Presenter
Michael A. Thompson, MD, PhD, FASCO
Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT02761187
Citation
J Clin Oncol 38: 2020 (suppl; abstr 8528)
DOI
10.1200/JCO.2020.38.15_suppl.8528
Abstract #
8528
Poster Bd #
428
Abstract Disclosures
Similar Videos & Slides
Speaker: Panel Discussion
Speaker: Panel Discussion
Videos & Slides
2024 ASCO Annual Meeting
Final results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous stem cell transplant (AuSCT) in patients (Pts) with multiple myeloma (MM).
Speaker: Sheeba K. Thomas, MD
Speaker: Sham Mailankody, MBBS